Navigation Links
Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
Date:9/2/2009

the natural lens following cataract extraction. IOL technologies include:
  • Monofocal IOL: Provides vision at one distance only and typically requires patient to wear reading glasses.
  • Multifocal IOLs: Designed to provide vision at all distances (near, intermediate, distance) and majority of patients no longer require reading glasses.
  • Accommodating IOLs: Designed to address presbyopia and loss of flexibility of natural lens due to aging by mimicking the ability of the natural lens to change focus, allowing the patient to see at all distances.

Market Size

  • Total current IOL market is estimated at $1.9 billion, growing to $2.7 billion by 2014*.
  • Accommodating IOLs are projected to grow to $600 million by 2014 (more than 20 percent of total IOL market)*.
  • In the U.S., only accommodating IOLs and multifocal IOLs are eligible for Medicare-reimbursement for correction of presbyopia.

* Source: MarketScope


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... bill provides for an unprecedented expansion of f...t if it is not for preserving and protecting human...ated." Charmaine Yoest ,, WASHINGTON, Nov. 2...Life Action President and CEO Dr. Charmaine Yoest ...sing the following statement: ,, "This was a p...
(Date:11/21/2009)... NH based medical credentialing software compa...to form a partnerhsip with Amerinet, Inc., the lea...ip will help to transform quality care within the ...us) November 21, 2009 -- ISG Group, LLC, doing bus...reement with Amerinet Inc., a leading national hea...
(Date:11/21/2009)... Linwood Group ask whether there is a secret t... , London, UK (PRWEB) Nove... to one in three of the adult UK population drinki...lcohol-related liver disease*, it is hardly a surp...itation programmes and residential centres for hel...
(Date:11/20/2009)...ss., Nov. 20 Following a recall by...removed from sale Shedd,s Country Crock ® Sid...Country Crock ® Side Dishes DELUXE Four Chees..., The following code dates and UPCs are affected...DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002183...
(Date:11/20/2009)...FA, Israel, November 20 ...ttp://www.CVSLMEDICAL.COM , a leading,developer of... announced that,the company,s Board of Directors h...pe, Canada and the Far East for its proprietary ne... all angioplasty (PCTA) procedures. , Car...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...r need specific child warnings on side effects, pe...ndation to toughen label on flu drugs for kids. , ...U.S. Food and Drug Administration advisory panel o... Both drugs are long-acting beta agonist medicatio...
...Profit Organizations to Receive Support from Assoc...hield Foundation, MASON, Ohio, Nov. 28 Anthem Bl...associates have pledged $1.5 million to support,no... campaign highlights,their integrity and commitmen...
...ov. 28 genX International, Inc and,IVFonline, LLC...hat,counterfeit Coda(R) products are being sold to...ured, sold or distributed by genX International,an... that the products are free from contamination, in...
...scientists at MIT and Harvard University and suppo...and Infectious Diseases, a component of the Nation...rom 43 P. falciparum-infected malaria patients in ...rly 6,000 P. falciparum genes were switched on or ...
...nother helpful role for p53, scientists say , ... long linked to suppressing the growth of cancer m...esearchers report. , In experiments with mice, re...ive, they had fewer offspring. A lack of p53 did...
...ors suffer minimal health problems and 90 per cent... a donor if a partner or family member needed a tr...ople published in the December issue of the UK-bas...tions of 339 patients who attended follow-up clini...
Other Medicine News:Health News:FDA Panel Backs Tougher Warning on Asthma Drugs for Kids 2Health News:FDA Panel Backs Tougher Warning on Asthma Drugs for Kids 3Health News:FDA Panel Backs Tougher Warning on Asthma Drugs for Kids 4Health News:Anthem Blue Cross and Blue Shield Foundation and Plan Associates Pledge $2.2 Million to Community Organizations in 2008 2Health News:Warning - Beware of Counterfeit Coda(R) Products 2Health News:Cancer-Suppressing Gene Tied to Female Fertility 2Health News:Live kidney donors report high satisfaction rates and minimal health problems 2Health News:Live kidney donors report high satisfaction rates and minimal health problems 3
(Date:11/20/2009)...swire/ -- The United States Court of Appeals for ... ruling yesterday, approving a settlement in the l...utical litigation against AstraZeneca Pharmaceutic...gi-bin/prnh/20080317/AQM144LOGO ) ,, The ruling...urchased the pharmaceutical giant,s prostate cance...
(Date:11/20/2009)...20 The National Association of Dru...a new initiative in the war on methamphetamine. T...lti-state electronic tracking program that enforce...edicines containing pseudoephedrine in real-time a...based on a system that was developed and tested in...
(Date:11/20/2009)...0 The Department of Hea...embers of priority groups that did not have previo...ics are being held statewide on Nov. 20-22. Friday... Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On Su.... to 8 p.m. ,, Individuals in the recommended ...
Breaking Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2U M Researchers Receive 241 8 Million Grant to Develop New Therapy for Neuropathic Pain 60987 1U M Researchers Receive 241 8 Million Grant to Develop New Therapy for Neuropathic Pain 60987 2The SCOOTER Store Surprises 9 11 First Responder 26amp 3B Merrick Firefighter With Power Chair 6094 1The SCOOTER Store Surprises 9 11 First Responder 26amp 3B Merrick Firefighter With Power Chair 6094 2The SCOOTER Store Surprises 9 11 First Responder 26amp 3B Merrick Firefighter With Power Chair 6094 3Once daily INTUNIV 28guanfacine 29 extended release tablets now available in US pharmacies 60983 1Once daily INTUNIV 28guanfacine 29 extended release tablets now available in US pharmacies 60983 2Once daily INTUNIV 28guanfacine 29 extended release tablets now available in US pharmacies 60983 3Once daily INTUNIV 28guanfacine 29 extended release tablets now available in US pharmacies 60983 4
...NORTH HOLLYWOOD, Calif., and CHICAGO, June 04, 200...tion (IMF)-supporting research,and providing educa...amilies, researchers and physicians-today said tha...al clinical trial shows the,combination of DOXIL(R...ival by 41%. The follow-up study also showed no in...
...2007 - Repros,Therapeutics Inc. (NasdaqGM:RPRX) an...3 study of Androxal(TM), an oral drug being,develo...ith,secondary hypogonadism. Further, Androxal demo...he study, compared to,Androgel(R), a cream which i...dy Details and Results , This six month, double-bl...
Other Medicine Technology:Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2Repros' Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism 2Repros' Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism 3Repros' Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism 4Repros' Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism 5
Multi Frequency Convex Endovaginal Transducer UST-9112-5
Multifrequency Bi-Plane Convex & Linear Transducer
Multi Frequency Prostate Biopsy Transducer UST-676P
Multi Frequency Prostate Biopsy Transducer UST-670P
Medicine Products: